Literature DB >> 34185292

The Mammary Tumor Microenvironment.

Colleen S Curran1, Suzanne M Ponik2,3.   

Abstract

A developing breast tumor is regulated by its tumor microenvironment (TME) which includes various immune cell subsets, fibroblasts, adipocytes, and endothelial and epithelial cells surrounded by an extracellular matrix (ECM). Breast tissue density is also a defining feature of breast cancer and plays an integral role in the exchange of biochemical cues between cells and the ECM. Cell signals from these interactions regulate tumor growth, metabolism, immunity, and invasion. The distinct organization of cells in the ECM generates structural patterns that are important in understanding disease development and progression. In this chapter, we discuss this complex interplay between the ECM and cells in the TME. Various models that mimic density are described to more fully understand the effect of ECM density on immunity, metabolism, tumorigenesis, and dormancy. Continued study of the interactions between cells and the ECM in the TME may provide needed biomarkers and therapeutic targets in breast cancer.

Entities:  

Keywords:  Breast cancer; Collagen; Dormancy; Mammographic density; Mechanotransduction; Metabolism; Metastasis; Migration; Tumor immunity; Tumor-associated collagen signatures (TACS)

Mesh:

Year:  2020        PMID: 34185292     DOI: 10.1007/978-3-030-59038-3_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  148 in total

Review 1.  Roles of the innate immune system in mammary gland remodeling during involution.

Authors:  Kamran Atabai; Dean Sheppard; Zena Werb
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

2.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo.

Authors:  J A Aguirre-Ghiso; D Liu; A Mignatti; K Kovalski; L Ossowski
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

3.  Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.

Authors:  J A Aguirre Ghiso; K Kovalski; L Ossowski
Journal:  J Cell Biol       Date:  1999-10-04       Impact factor: 10.539

4.  Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells.

Authors:  Craig E Barcus; Kathleen A O'Leary; Jennifer L Brockman; Debra E Rugowski; Yuming Liu; Nancy Garcia; Menggang Yu; Patricia J Keely; Kevin W Eliceiri; Linda A Schuler
Journal:  Breast Cancer Res       Date:  2017-01-19       Impact factor: 6.466

Review 5.  Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.

Authors:  Angélica Aponte-López; Ezequiel M Fuentes-Pananá; Daniel Cortes-Muñoz; Samira Muñoz-Cruz
Journal:  J Immunol Res       Date:  2018-02-05       Impact factor: 4.818

6.  CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy.

Authors:  Amira A Barkal; Rachel E Brewer; Maxim Markovic; Mark Kowarsky; Sammy A Barkal; Balyn W Zaro; Venkatesh Krishnan; Jason Hatakeyama; Oliver Dorigo; Layla J Barkal; Irving L Weissman
Journal:  Nature       Date:  2019-07-31       Impact factor: 49.962

7.  Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages.

Authors:  Gaili An; Fang Wu; Shangke Huang; Lu Feng; Jun Bai; Shanzhi Gu; Xinhan Zhao
Journal:  Oncol Rep       Date:  2019-10-01       Impact factor: 3.906

8.  Tumor macrophages are pivotal constructors of tumor collagenous matrix.

Authors:  Ran Afik; Ehud Zigmond; Milena Vugman; Mordehay Klepfish; Elee Shimshoni; Metsada Pasmanik-Chor; Anjana Shenoy; Elad Bassat; Zamir Halpern; Tamar Geiger; Irit Sagi; Chen Varol
Journal:  J Exp Med       Date:  2016-10-03       Impact factor: 14.307

9.  The paradoxical functions of EGFR during breast cancer progression.

Authors:  Remah Ali; Michael K Wendt
Journal:  Signal Transduct Target Ther       Date:  2017-01-20

10.  CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation.

Authors:  Pradip Bajgain; Supannikar Tawinwung; Lindsey D'Elia; Sujita Sukumaran; Norihiro Watanabe; Valentina Hoyos; Premal Lulla; Malcolm K Brenner; Ann M Leen; Juan F Vera
Journal:  J Immunother Cancer       Date:  2018-05-10       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.